DexTech Medical Valuation Multiples

DexTech Medical Overview

About DexTech Medical

DexTech Medical AB is a Swedish research company specializing in drug development for urological oncology, with a prominent focus on prostate cancer. The company develops drug candidates using a proprietary carbohydrate platform, advancing treatments aimed at castration-resistant prostate cancer and related conditions. Its operations center on research, development, and licensing of these drug candidates. It has four drug candidates: OsteoDex, SomaDex, PSMA-binding conjugates, and GuaDex.

Founded

2004

HQ

Employees

1

Website

dextechmedical.com

Sectors

BiopharmaceuticalsBioTech

Financials (FY)

Revenue: —

EBITDA: ($120K)

EV

$19M

Valuation Multiples

Multiples.vc

Start free trial

DexTech Medical Financials

DexTech Medical reported last fiscal year revenue of — and negative EBITDA of ($120K).

In the same fiscal year, DexTech Medical generated $351K in gross profit, ($120K) in EBITDA losses, and had net loss of ($527K).

DexTech Medical P&L

In the most recent fiscal year, DexTech Medical reported revenue of — and EBITDA of ($120K).

DexTech Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX

DexTech Medical Stock Performance

DexTech Medical has current market cap of $20M, and enterprise value of $19M.

DexTech Medical's stock price is $1.08.

DexTech Medical Valuation Multiples

DexTech Medical trades at (155.6x) EV/EBITDA.

DexTech Medical Financial Valuation Multiples

As of April 19, 2026, DexTech Medical has market cap of $20M and EV of $19M.

Equity research analysts estimate DexTech Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

DexTech Medical has a P/E ratio of (38.0x).

DexTech Medical Margins & Growth Rates

DexTech Medical's revenue in the last fiscal year grew by —.

DexTech Medical's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.9M for the same period.

DexTech Medical Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

DexTech Medical M&A Activity

DexTech Medical acquired XXX companies to date.

Last acquisition by DexTech Medical was on XXXXXXXX, XXXXX. DexTech Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

DexTech Medical Investment Activity

DexTech Medical invested in XXX companies to date.

DexTech Medical made its latest investment on XXXXXXXX, XXXXX. DexTech Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).